Feature | October 02, 2017

Most Popular Cardiac Technology Content in September 2017 on DAIC

Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.

The biggest cardiac technology story in September was Abbott pulled the Absorb Bioresorbable scaffold stent off the market because poor sales.

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September, based on website analytics of the month’s 126,393 pageviews:

Top Cardiology Technology Articles

1. Abbott Will End Sales of Absorb Bioresorbable Stent

2. The Future of Cardiology: 17 Technologies to Watch

3. Oxygen Therapy Does Not Improve Survival in Heart Attack Patients

4. Israeli Hospital Completes First Implant of CORolla Heart Failure Device

5. CT Calcium Scoring for Heart Disease May Lead to Prevention, Treatments

6. Biotronik's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial

7. Abbott, St. Jude Medical Fixes Cybersecurity Vulnerabilities of its Pacemakers, ICDs

8. Intracardiac Echo Should be More Widely Adopted to Minimize Radiation in Catheter Ablations

9. Philips to Develop FFR-Angiography in Partnership With HeartFlow

10. World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy

11. Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System

12. Late-breaking Trial Presentations at ESC 2017

13. Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR

14. VIVA 2017 Late-breaking Clinical Trial Presentations

15. CASTLE-AF Study Results Indicate Catheter Ablation of Atrial Fibrillation as First-Line Treatment for Heart Failure Patients

 

Top 5 Cardiology Videos:

1. VIDEO: Future of Strain Imaging

2. VIDEO: CRT Optimization Using Echo

3. VIDEO: What is Myocardial Strain Imaging?

4. VIDEO: Transcatheter Tricuspid Valve Repair and Replacement Technologies

5. VIDEO: Mitral and Tricuspid Valve Repair Technologies

 

 

Related Most Popular Cardiology Technology Content Links:

Most Popular Cardiac Technology Content in August 2017 on DAIC

Most Popular Cardiac Technology Content in July 2017 on DAIC

Most Popular DAIC Content in June 2017

Most Popular DAIC Content in May 2017

Most Popular Cardiology Articles of 2016 From DAIC

Related Content

News | Stents | July 24, 2020
July 24, 2020 — CeloNova BioSciences Inc.
Coronary and Peripheral Stent Market Expected to Double Through 2025
News | Stents | May 28, 2020
May 28, 2020 — The rising incidence of cardiovascular disease has prompted people to seek timely treatment to improve
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration. #SCAI2020

The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration.

News | Stents | May 17, 2020
May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP)
Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the 2020 Cardiovascular Research Technologies (CRT) Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinforcing the differentiation of the Orsiro coronary drug-eluting stent (DES), which is the first DES to outperform Xience.
News | Stents | February 24, 2020
February 24, 2020 — Biotronik announced three-year data from the...
The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.

The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.

Feature | Stents | February 11, 2020 | Saloni Walimbe
Cardiovascular diseases (CVDs) are among the leading causes of death across the globe.
Global Cardiovascular Stent Market Poised for Almost 7 Percent Growth Through 2025
News | Stents | August 21, 2019
Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the global...
The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral Vascular's Covera Vascular Covered Stent for the treatment of a stenosis or blockage which has developed anywhere in the access circuit of patients on hemodialysis using an arteriovenous (AV) fistula.
Technology | Stents | April 03, 2019
April 3, 2019 — The U.S.

A comparison of stent strut thickness between the Orsiro stent, pictured, and the market-leading stents on the U.S. and European markets. Vendors have been working toward reducing strut thickness to help improve overall clinical outcomes. Orsiro is now the smallest strut stent available on the market. 

Feature | Stents | February 22, 2019 | Dave Fornell, Editor
February 22, 2019 — The U.S.
The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.

The Medtronic Resolute Integrity drug-eluting stent (DES) is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data.

Feature | Stents | January 29, 2019 | Dave Fornell, Editor
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years
The Indian-made SMT SuperFlex stent. SMT has been developing stents and other interventional products designed to be a more affordable, home-grown option for the growing Indian market.

The Indian-made SMT SuperFlex stent. SMT has been developing stents and other interventional products designed to be a more affordable, home-grown option for the growing Indian market.

News | Stents | January 22, 2019
The rise cardiovascular disease has been instrumental in fueling the coronary stent market share in the past few year